Previous Close | 0.9701 |
Open | 0.9700 |
Bid | 0.9001 x 800 |
Ask | 1.2000 x 900 |
Day's Range | 0.9651 - 0.9900 |
52 Week Range | 0.9500 - 3.3400 |
Volume | |
Avg. Volume | 63,761 |
Market Cap | 16.41M |
Beta (5Y Monthly) | 0.92 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.6300 |
Earnings Date | Nov 02, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Dec 20, 2019 |
1y Target Est | N/A |
Conference call and webcast on November 2, 2023 at 5 p.m. ETRADNOR, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) (“Safeguard” or the “Company”) today announced financial results for the three and nine months ended September 30, 2023. THIRD QUARTER 2023 HIGHLIGHTS Financial Results Cash, cash equivalents and restricted cash totaled $15.7 million at September 30, 2023.The carrying value of the Company’s ownership interests totaled $14.8 million at September 30, 2
Conference Call and Webcast Scheduled for Thursday, November 2nd at 5:00 pm ETRadnor, Pa, Oct. 24, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (NASDAQ:SFE) will release its financial results for the third quarter ended September 30, 2023 after the market close on Thursday, November 2, 2023. CONFERENCE CALL AND WEBCAST DETAILS Please call 10-15 minutes prior to the call to register. Date: Thursday, November 2, 2023 Time: 5:00 pm ET Live Number: 877-407-0989 Webcast link: https://www.webc
RADNOR, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (Nasdaq:SFE) (“Safeguard” or the “Company”) today announced that its Board of Directors (the “Board”) has approved a plan to cease the registration of the Company’s common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), following the completion of a proposed reverse stock split transaction, which will be followed immediately by a forward stock split, and to delist its shares of common sto